China India Germany covid-19 outbreak vaccine prevention China India Germany

Germany's BioNTech, Fosun launch covid vaccine trial in China

Reading now: 466
www.livemint.com

COVID-19 vaccine candidate in China.The randomized, placebo-controlled, observer-blinded Phase 1 clinical trial in China will enroll 144 healthy subjects to evaluate the safety and immunogenicity of the vaccine as well as to confirm dose selection, BioNTech said in a statement."The study is designed to support the regulatory approval process for the Chinese market and intends to confirm that the safety and immunogenicity profile observed in participants from the German and U.S.

trials is comparable to that of Chinese participants," BioNTech said in a statement.The trial is part of BioNTech’s global development program aimed at supporting a global supply upon regulatory approval.BioNTech said the dose range selection was determined based on.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA